mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.27 |
0.001 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.25 |
0.001 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |